| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $6.05B | $5.93B | $6.16B |
| YoY Revenue Growth % | +2.0% | -3.7% | — |
| Gross Profit | $2.11B | $2.01B | — |
| Gross Margin % | 34.8% | 33.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $512.2M | $538.6M | $677.9M |
| Operating Margin % | 8.5% | 9.1% | 11.0% |
| Net Income (GAAP) | $376.8M | $418.4M | $519.2M |
| EBITDA (Normalized) | $682.3M | $698.3M | $899.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $434.8M | $528.1M | $535.8M |
| Capital Expenditures (CapEx) | $212.7M | $199.6M | $277.2M |
| Free Cash Flow (FCF) | $222.1M | $328.5M | $258.6M |
| FCF Margin % | 3.7% | 5.5% | 4.2% |
| Return on Invested Capital (ROIC %) | 17.4% | 19.4% | 12.0% |
| Cash & Short-Term Equivalents | $330.3M | $288.9M | — |
| Total Debt (Short + Long Term) | $480.8M | $482.7M | $1.73B |
| Total Stockholders' Equity | $2.17B | $2.00B | $3.55B |